Research Article| Volume 209, ISSUE 2, P487-491, April 2010

Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm



      Apolipoprotein E (ApoE) genotype has been associated with systemic inflammation and athero-thrombosis however the association with abdominal aortic aneurysm (AAA) has not been previously examined. We assessed the association between ApoE genotype with AAA presence and growth, and serum C-reactive protein (CRP).


      Serum concentrations of CRP (in 1358 men) and 6 single nucleotide polymorphisms (SNPs) for ApoE (in 1711 men) were examined in subjects from the Health In Men Study. 640 men with small AAAs were followed by ultrasound surveillance for a mean of 4.1 years.


      There was no association between ApoE genotype and AAA presence. Men heterozygote for the ApoE p.Arg176Cys polymorphism had slower AAA growth, odds ratio for AAA progression ≥ median 0.41, 95% confidence intervals 0.21–0.80, p = 0.01. Men heterozygote for the ApoE g.50093756A > G polymorphism had slightly more rapid AAA growth, odds ratio for AAA progression ≥ median 1.48, 95% confidence intervals 1.02–2.14, p = 0.04. None of the ApoE SNPs were associated with AAA growth however taking into account multiple testing. Two SNPs in ApoE were associated with serum CRP under a co-dominant model, ApoE p.Cys130Arg (SNP ID rs429358), p = 0.00003 and ApoE g.50114786A > G (SNP ID rs4420638), p = 0.00013. Adjusting for other risk factors plus serum creatinine the ɛ4 allele was associated with lower serum CRP under a dominant model, coefficient 0.089, p = 0.002.


      We found no consistent association between ApoE genotype and AAA. We confirmed an association between ApoE genotype and serum CRP.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kockx M.
        • Jessup W.
        • Kritharides L.
        Regulation of endogenous apolipoprotein E secretion by macrophages.
        Arterioscler Thromb Vasc Biol. 2008; 28: 1060-1067
        • Mahley R.W.
        • Rall Jr., S.C.
        Apolipoprotein E far more than a lipid transport protein.
        Annu Rev Genom Hum Genet. 2000; 1: 507-537
        • Klos K.L.
        • Sing C.F.
        • Boerwinkle E.
        • et al.
        Consistent effects of genes involved in reverse cholesterol transport on plasma lipid and apolipoprotein levels in CARDIA participants.
        Arterioscler Thromb Vasc Biol. 2006; 26: 1828-1836
        • Chasman D.I.
        • Kozlowski P.
        • Zee R.Y.
        • Kwiatkowski D.J.
        • Ridker P.M.
        Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein. LDL-cholesterol, and apoE protein.
        Genes Immun. 2006; 7: 211-219
        • Eiriksdottir G.
        • Aspelund T.
        • Bjarnadottir K.
        • et al.
        Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study.
        Atherosclerosis. 2006; 186: 222-224
        • Lange L.A.
        • Burdon K.
        • Langefeld C.D.
        • et al.
        Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study.
        Ann Hum Genet. 2006; 70: 717-725
        • Tziakas D.N.
        • Chalikias G.K.
        • Antonoglou C.O.
        • et al.
        Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.
        J Am Coll Cardiol. 2006; 48: 2471-2481
        • März W.
        • Scharnagl H.
        • Hoffmann M.M.
        • Boehm B.O.
        • Winkelmann B.R.
        The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study).
        Eur Heart J. 2004; 25: 2109-2119
        • Bennet A.M.
        • Di Angelantonio E.
        • Ye Z.
        • et al.
        Association of apolipoprotein E genotypes with lipid levels and coronary risk.
        JAMA. 2007; 298: 1300-1311
        • Song Y.
        • Stampfer M.J.
        • Liu S.
        Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease.
        Ann Intern Med. 2004; 141: 137-147
        • Golledge J.
        • Muller J.
        • Daugherty A.
        • Norman P.
        Abdominal aortic aneurysm: pathogenesis and implications for management.
        Arterioscler Thromb Vasc Biol. 2006; 26: 2605-2613
        • Daugherty A.
        • Manning M.W.
        • Cassis L.A.
        Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.
        J Clin Invest. 2000; 105: 1605-1612
        • Gerdes L.U.
        • Lindholt J.S.
        • Vammen S.
        • Henneberg E.W.
        • Fasting H.
        Apolipoprotein E genotype is associated with differential expansion rates of small abdominal aortic aneurysms.
        Br J Surg. 2000; 87: 760-765
        • Gregg R.E.
        • Brewer Jr., H.B.
        The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of polipoprotein B-containing lipoproteins in humans.
        Clin Chem. 1988; 34: B28-32
        • Banares V.G.
        • Peterson G.
        • Aguilar D.
        • et al.
        Association between the APOE*4 allele and atherosclerosis is age dependent among Argentine males.
        Hum Biol. 2005; 77: 247-256
        • Jamrozik K.
        • Norman P.E.
        • Spencer C.A.
        • et al.
        Screening for abdominal aortic aneurysm: lessons from a population-based study.
        Med J Aust. 2000; 173: 345-350
        • Norman P.E.
        • Jamrozik K.
        • Lawrence-Brown M.M.
        • et al.
        Impact of screening on mortality from abdominal aortic aneurysm: results of a large, population-based randomised controlled trial.
        BMJ. 2004; 329: 1259-1262
        • Golledge J.
        • Clancy P.
        • Jamrozik K.
        • Norman P.E.
        Obesity, adipokines, and abdominal aortic aneurysm: health in men study.
        Circulation. 2007; 116: 2275-2279
        • Norman P.E.
        • Flicker L.
        • Almeida O.P.
        • et al.
        Cohort Profile: the Health In Men Study (HIMS).
        Int J Epidemiol. 2009; 38: 48-52
        • Norman P.
        • Spencer C.A.
        • Lawrence-Brown M.M.
        • Jamrozik K.
        C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men.
        Circulation. 2004; 110: 862-866
        • Golledge J.
        • Clancy P.
        • Jones G.T.
        • et al.
        Possible association between genetic polymorphisms in transforming growth factor beta receptors, serum transforming growth factor beta1 concentration and abdominal aortic aneurysm.
        Br J Surg. 2009; 96: 628-632
        • Mazzone T.
        • Reardon C.
        Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3.
        J Lipid Res. 1994; 35: 1345-1353
        • Ali K.
        • Middleton M.
        • Pure E.
        • Rader D.J.
        Apolipoprotein E suppresses the type I inflammatory response in vivo.
        Circ Res. 2005; 97: 922-927
        • Dallongeville J.
        • Lussier-Cacan S.
        • Davignon J.
        Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.
        J Lipid Res. 1992; 33: 447-454
        • Grönroos P.
        • Raitakari O.T.
        • Kähönen M.
        • et al.
        Association of high sensitive C-reactive protein with apolipoprotein E polymorphism in children and young adults: the Cardiovascular Risk in Young Finns Study.
        Clin Chem Lab Med. 2008; 46: 179-186
        • Ridker P.M.
        • Pare G.
        • Parker A.
        • et al.
        Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study.
        Am J Hum Genet. 2008; 82: 1185-1192
        • Ortiz M.A.
        • Campana G.L.
        • Woods J.R.
        • et al.
        Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein e-deficient mice.
        Exp Biol Med (Maywood). 2009; 234: 624-631
        • Angelopoulos T.J.
        • Miles M.P.
        • Lowndes J.
        • et al.
        Apolipoprotein E genotype and sex influence C-reactive protein levels regardless of exercise training status.
        Metabolism. 2008; 57: 1204-1210
        • Berrahmoune H.
        • Herbeth B.
        • Siest G.
        • Visvikis-Siest S.
        Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles.
        Genes Immun. 2007; 8: 352-359
        • Rontu R.
        • Ojala P.
        • Hervonen A.
        • et al.
        Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians.
        Clin Endocrinol (Oxf). 2006; 64: 265-270